This applies independently of the groups of patients with titin antibodies, including MG patients with thymoma, hyperplastic or involuted thymus, early or late onset of the disease (which may follow different pathogenic mechanisms), or even non-MG patients. This evidence concerns the gene TTN and thymoma.